Log in

CVE:QPTQuest PharmaTech Stock Price, Forecast & News

C$0.10
0.00 (-4.55 %)
(As of 04/7/2020 01:08 AM ET)
Add
Compare
Today's Range
C$0.10
Now: C$0.11
C$0.11
50-Day Range
C$0.06
MA: C$0.11
C$0.12
52-Week Range
C$0.06
Now: C$0.11
C$0.18
Volume10,300 shs
Average Volume33,879 shs
Market CapitalizationC$17.58 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Quest PharmaTech Inc., a biotechnology company, develops and commercializes antibody based immunotherapeutic products for cancer. It operates in two segments, Biopharmaceutical/Pharmaceutical Products and Consumer/Cosmetic Products. The company focuses on combinatorial immunotherapeutic approaches to cancer by using monoclonal antibodies of the immunoglobulin G or E subclass in combination with chemotherapy/immune-adjuvant. Its lead product candidate is Oregovomab, a monoclonal antibody, which is in Phase II clinical trial for the treatment of ovarian cancer. The company also owns the Photodynamic therapy technology for oncology and dermatology applications; and markets Bellus Skin serum, an anti-wrinkle skin care product, as well as develops Mab AR 9.6 against truncated O-glycan on MUC16 for targeted cancer therapy applications. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.42 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-780-4481400

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$38,871.00
Cash FlowC$0.00 per share
Book ValueC($0.08) per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$17.58 million
Next Earnings Date6/4/2020 (Estimated)
OptionableNot Optionable

Receive QPT News and Ratings via Email

Sign-up to receive the latest news and ratings for QPT and its competitors with MarketBeat's FREE daily newsletter.


Quest PharmaTech (CVE:QPT) Frequently Asked Questions

How has Quest PharmaTech's stock been impacted by COVID-19 (Coronavirus)?

Quest PharmaTech's stock was trading at C$0.11 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, QPT shares have decreased by 4.5% and is now trading at C$0.11. View which stocks have been mosted impacted by Coronavirus.

When is Quest PharmaTech's next earnings date?

Quest PharmaTech is scheduled to release its next quarterly earnings announcement on Thursday, June 4th 2020. View our earnings forecast for Quest PharmaTech.

Has Quest PharmaTech been receiving favorable news coverage?

News headlines about QPT stock have trended very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Quest PharmaTech earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutQuest PharmaTech.

Who are some of Quest PharmaTech's key competitors?

What other stocks do shareholders of Quest PharmaTech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Quest PharmaTech investors own include Aphria (APHA) and Canadian Metals (CME).

Who are Quest PharmaTech's key executives?

Quest PharmaTech's management team includes the following people:
  • Dr. Ragupathy Madiyalakan, CEO & Director
  • Mr. Pierre Vermette, Chief Financial Officer
  • Mr. Thomas Woo, VP of Product Devel.
  • Mr. Roger Andrews, Head of Investor Relations & Corp. Communications
  • Mr. Douglas C. Bachman, VP of Corp. Devel. (Age 65)

What is Quest PharmaTech's stock symbol?

Quest PharmaTech trades on the Canadian Venture Exchange (CVE) under the ticker symbol "QPT."

How do I buy shares of Quest PharmaTech?

Shares of QPT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Quest PharmaTech's stock price today?

One share of QPT stock can currently be purchased for approximately C$0.11.

How big of a company is Quest PharmaTech?

Quest PharmaTech has a market capitalization of C$17.58 million and generates C$38,871.00 in revenue each year.  View additional information about Quest PharmaTech.

What is Quest PharmaTech's official website?

The official website for Quest PharmaTech is http://www.questpharmatech.com/.

How can I contact Quest PharmaTech?

Quest PharmaTech's mailing address is 8123 Roper Rd NW, EDMONTON, AB T6E 6S4, Canada. The company can be reached via phone at +1-780-4481400.

This page was last updated on 4/7/2020 by MarketBeat.com Staff

Featured Article: Capital Gains Distribution

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel